Table of Contents Table of Contents
Previous Page  289 / 398 Next Page
Information
Show Menu
Previous Page 289 / 398 Next Page
Page Background

284

Improvement measures for complete excision of the

malignant tongue tumour: retrospective factor analysis of

101 consecutive cases

O. Dugena

∗

, N. Uwadiae, C. Avery, Borgulya, P. Bujtar

Department of Maxillofacial/Head and Neck Surgery University

Hospitals Leicester, Leicester, United Kingdom

Background:

Complete local excision of tongue squamous cell

carcinoma (SCC) is the primary surgical aim in disease control.

Method:

A retrospective analysis was performed among those

who underwent resection of tongue cancer between 1 September

2010 and 8 July 2015.

Results:

The population mean age is 63.9 (SD, 14.5) years, 53

were female. SCC was localised on the ventral aspect in 18 cases,

5 on the dorsum, 40 and 37 on the left and right lateral tongue.

Postoperative staging were 54 T1, 30 T2, 8 T3 and 9 T4. Neck

dissection was performed in 63 instances and found 9 N1, 12 N2b

and 4 N2c with 38 N0 disease negative necks. Two investigated

ordinal type primary outcome measures were used: closest radial

and closest deep margin. Over 30 pre-, intra- or postoperative

factors impact was analysed.

Conclusion:

At least four factors for each outcome measures were

identified which can predict close not sufficient excision margins.

Using the coefficient and confidence intervals to be provided cor-

rection of techniques is possible. Independently the publication

would also suggest some baselines for certain measures as to avoid

incomplete excisions. Control over the identified statistically sig-

nificant predictors can eliminate incomplete excisions potentially.

Incomplete or narrow margin excision of tongue tumour is still

rare possible. Control over the margins however mostly possible

for good outcomes this is a must criteria. All possible steps should

be followed to prevent incomplete excisions.

http://dx.doi.org/10.1016/j.ijom.2017.02.955

Comorbidity scoring in head and neck cancer patients

B. Edwards

∗

, K. Stewart, A. Al-Rikabi, C. Thomas

Cardiff and Vale University Health Board, United Kingdom

Background:

Comorbidities in head and neck cancer patients can

prohibit the use of preferred therapy and have a negative influence

on the effectiveness of treatment, as well as impact on cancer

survival statistics. The Adult Comorbidity Evaulation-27 (ACE-

27) is specifically designed for assessing comorbidities in patients

with cancer. The National Cancer Intelligence Network (NCIN)

recommends the collection of ACE-27 scores for all adult cancer

patients. All patients discussed in the head and neck cancer mul-

tidisciplinary team (MDT) should have a correct ACE-27 score

documented.

Methods:

The audit was a retrospective review of case notes and

letters. 56 patients were identified from the DAHNO report as

discussed in the MDT February to August 2015. Two investigators

independently assessed the notes to complete scores. These were

later compared with scores given during the MDT meeting. Data

were recorded on an Excel spreadsheet and quantitative analysis

performed.

Results:

40 of the 56 (71%) patients had a co morbidity score

recorded in the DAHNO report. 2 patients were excluded. 60.5%

(

n

= 23/38) had scores which were correct on recalculation. Out

of the total eligible patients, 42.6% (

n

= 23/54) had correct score

recorded.

Conclusion:

Assessing comorbidities in newly-diagnosed can-

cer cases is important for informed patient treatment decisions,

quality of life considerations, and to ensure high-quality cancer

statistics. This audit has highlighted poor calculation and recor-

ding of comorbidity scores. We discuss some important steps we

have undertaken to ensure correct score calculation. We encourage

all head and neck cancer units in the United Kingdom to undertake

this audit to ensure accurate scoring and management.

http://dx.doi.org/10.1016/j.ijom.2017.02.956

Synchronous unilateral histologically different three parotid

tumours

S. Farook

∗

, A. Jay, S. Morley, N. Kalavrezos, Z. Sadiq

Head and Neck Department, University College London

Hospital, London, United Kingdom

Background:

Multiple tumours of unilateral parotid gland with

different histology are rare. Although studies and case reports have

presented this phenomenon no studies were found with more than

two histologically confirmed tumours

Methods:

We present a case report of a 42-year-old gentleman

who presented with an exophytic; rapidly growing left parotid

lesion where the initial diagnosis of sarcomatous lesion was super-

seded by the final diagnosis of three histologically confirmed

tumours.

Results:

Patient’s medical history, initial clinical, radiological and

histological diagnosis and the final histological diagnosis are pre-

sented. The surgical management of this patient is also discussed.

Conclusion:

Synchronous multiple unilateral, histologically dif-

ferent parotid tumours usually include two. We present a patient

with three histologically confirmed tumours within a unilateral

parotid and how best to manage such cases. The importance of

preoperative radiological and histological investigations together

with a multidisciplinary approach in managing such patients is

highlighted.

http://dx.doi.org/10.1016/j.ijom.2017.02.957

Surgical management of deep lobe parotid tumours,

presentation of three clinical cases and a review of the

literature

S. Farooq

â'^

, D. Gahir, T. Malins

University Hospital of North Midlands, Stoke-on-Trent, United

Kingdom

Background:

Tumours of the parapharyngeal space occur infre-

quently, accounting for 0.5% of head and neck neoplasms. A

majority of these are benign and approximately 50% of these arise

from salivary glands as pleomorphic adenomas. These tumours

although benign can prove to be a challenge to remove surgically

due to the complex surrounding anatomy. The literature describes

several approaches including the transcervical approach with or

without lip split and mandibulotomy, transparotid combined with

trans-cervical, transoral or transpalatal approaches